A Randomized Trial of Sirolimus (Rapamune(R)) for Relapse Prevention in Patients With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
Latest Information Update: 26 Sep 2024
At a glance
- Drugs Sirolimus (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 06 Sep 2024 Planned End Date changed from 31 Aug 2028 to 30 Jun 2030.
- 06 Sep 2024 Planned primary completion date changed from 31 Aug 2026 to 30 Jun 2030.
- 02 Aug 2024 Planned End Date changed from 31 Aug 2024 to 31 Aug 2028.